NBIX - Neurocrine Biosciences, Inc.
IEX Last Trade
127.06
-1.370 -1.078%
Share volume: 1,236,878
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$128.43
-1.37
-1.07%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-01 | 2023-02-09 | 2023-05-03 | 2023-08-01 | 2023-10-31 | 2024-02-09 | 2024-05-01 | 2024-08-01 | |
| Cash flow financing | 11.400 M | 24.600 M | 8.200 M | 2.900 M | 18.800 M | 35.400 M | 69.900 M | -293.000 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 98.800 M | 143.000 M | -125.200 M | 179.600 M | 212.000 M | 123.500 M | 130.300 M | 64.600 M | |
| Net income | 68.500 M | 89.000 M | -76.600 M | 95.500 M | 83.100 M | 147.700 M | 43.400 M | 65.000 M | |
| Depreciation | 4.000 M | 4.400 M | 5.000 M | 5.100 M | 5.500 M | 5.700 M | 6.200 M | 7.300 M | |
| Changes in inventories | 37.000 M | 35.100 M | 33.400 M | 31.700 M | 28.800 M | 38.300 M | 37.200 M | 42.500 M | |
| Changes in receivables | 301.200 M | 350.000 M | 391.600 M | 387.600 M | 417.800 M | 439.300 M | 450.700 M | 468.200 M | |
| Investing Cashflow | -61.300 M | -115.600 M | -42.100 M | -125.900 M | -97.300 M | -201.800 M | -55.000 M | -28.200 M | |
| Net Borrowings | -698.100 M | -899.000 M | -838.300 M | -907.600 M | -1.033 B | -959.300 M | -1.188 B | -1.159 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 1.700 M | -1.800 M | -8.500 M | -6.800 M | -7.600 M | -5.400 M | -11.200 M | -11.600 M | |
| Cash Change | 799.400 M | 989.300 M | 894.600 M | 976.700 M | 1.095 B | 1.032 B | 1.211 B | 1.039 B |